18:22 GMT22 April 2021
Listen Live
    Europe
    Get short URL
    by
    2212
    Subscribe

    Earlier this year, use of the AstraZeneca coronavirus vaccine was suspended in some countries following reports of severe side-effects, including a rare blood condition that causes clots and haemorrhages.

    Germany's vaccine regulator, the Paul Ehrlich Institute (PEI) said it has recorded 31 cases of a rare blood clot in the brain after people were vaccinated against COVID-19 with an AstraZeneca jab. 

    Nine of these cases have resulted in deaths, the PEI added. 

    According to the institute, the registered cases are linked to sinus vein thrombosis, or CSVT – in 19 of them, doctors recorded blood platelet deficiency, or thrombocytopenia. All of the cases except two concerned women aged 20-63 – the two men were 36 and 57 years old. 

    In a separate development, two of Berlin's state hospital groups Charite and Vivantes have stopped administering the AstraZeneca COVID-19 vaccine to women under the age of 55, Reuters reported, citing Tagesspiegel.

    Earlier this year, the use of the AstraZeneca COVID-19 vaccine was suspended in several countries following reports of severe blood clots in several people who were inoculated. The European Medicines Agency later ruled that the vaccine is safe.

    Tags:
    blood clots, AstraZeneca, vaccine, Germany
    Community standardsDiscussion